Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Angadi VM, Kambagiri P, Jindal A. Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations. Indian J Crit Care Med 2025;29(1):90.
References
1.
Li X, Liu C, Mao Z, Qi S, Song R, Zhou F
. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis. J Crit Care. 2020; 63:187-195.
DOI: 10.1016/j.jcrc.2020.09.007.
View
2.
Jain A, Singam A, Mudiganti V
. Recent Advances in Immunomodulatory Therapy in Sepsis: A Comprehensive Review. Cureus. 2024; 16(3):e57309.
PMC: 11059166.
DOI: 10.7759/cureus.57309.
View
3.
Robey R, Logue C, Caird C, Hansel J, Hellyer T, Simpson J
. Immunomodulatory drugs in sepsis: a systematic review and meta-analysis. Anaesthesia. 2024; 79(8):869-879.
DOI: 10.1111/anae.16263.
View
4.
Ghosh I, Sangha S, Pandey G, Srivastava A
. Efficacy of Polymyxin B Hemoperfusion for Treatment of Sepsis. Indian J Crit Care Med. 2024; 28(10):930-934.
PMC: 11471987.
DOI: 10.5005/jp-journals-10071-24805.
View
5.
Mithal L, Arshad M, Swigart L, Khanolkar A, Ahmed A, Coates B
. Mechanisms and modulation of sepsis-induced immune dysfunction in children. Pediatr Res. 2021; 91(2):447-453.
PMC: 9752201.
DOI: 10.1038/s41390-021-01879-8.
View